These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 25082814)
1. Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer. Liu D; Xiong H; Ellis AE; Northrup NC; Rodriguez CO; O'Regan RM; Dalton S; Zhao S Cancer Res; 2014 Sep; 74(18):5045-56. PubMed ID: 25082814 [TBL] [Abstract][Full Text] [Related]
2. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. Klopfleisch R; Lenze D; Hummel M; Gruber AD BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas. Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors. Bergholtz H; Lien T; Lingaas F; Sørlie T J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):171-183. PubMed ID: 35932380 [TBL] [Abstract][Full Text] [Related]
5. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060 [TBL] [Abstract][Full Text] [Related]
6. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs. Watson J; Wang T; Ho KL; Feng Y; Mahawan T; Dobbin KK; Zhao S Breast Cancer Res; 2023 Oct; 25(1):114. PubMed ID: 37789381 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer. Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566 [TBL] [Abstract][Full Text] [Related]
8. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer? Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453 [TBL] [Abstract][Full Text] [Related]
9. Cross-species oncogenic signatures of breast cancer in canine mammary tumors. Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis. Seung BJ; Cho SH; Kim SH; Lim HY; Sur JH PLoS One; 2020; 15(2):e0229031. PubMed ID: 32059046 [TBL] [Abstract][Full Text] [Related]
11. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer. Lee HJ; Han HJ; Lee JY; Son WC Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384 [TBL] [Abstract][Full Text] [Related]
12. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis. Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897 [TBL] [Abstract][Full Text] [Related]
13. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors. Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231 [TBL] [Abstract][Full Text] [Related]
14. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904 [TBL] [Abstract][Full Text] [Related]
15. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system. van Garderen E; Schalken JA Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808 [TBL] [Abstract][Full Text] [Related]
16. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas. Klopfleisch R; Lenze D; Hummel M; Gruber AD Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801 [TBL] [Abstract][Full Text] [Related]
17. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance. Abadie J; Nguyen F; Loussouarn D; Peña L; Gama A; Rieder N; Belousov A; Bemelmans I; Jaillardon L; Ibisch C; Campone M Breast Cancer Res Treat; 2018 Jan; 167(2):459-468. PubMed ID: 29063312 [TBL] [Abstract][Full Text] [Related]
18. Next-generation RNA sequencing of FFPE subsections reveals highly conserved stromal reprogramming between canine and human mammary carcinoma. Amini P; Nassiri S; Ettlin J; Malbon A; Markkanen E Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31308057 [TBL] [Abstract][Full Text] [Related]
20. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study. Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]